U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | Contact Us | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages

Start Over | Back to Previous Screen

Bupivacaine Hydrochloride and Epinephrine Injection
Status: Currently in Shortage
»Date first posted: 02/20/2018
»Therapeutic Categories: Anesthesia

Expand all

Fresenius Kabi USA, LLC (Revised 03/10/2023)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Sensorcaine w/EPI 0.25% (125 mg per 50 mL) (2.5 mg per mL) MDV (NDC 63323-461-57) Next release not available at this time. Demand increase for the drug
Sensorcaine w/EPI 0.5% (250 mg per 50 mL) (5 mg per mL) MDV (NDC 63323-463-57) Available Check wholesalers for inventory. Demand increase for the drug
Sensorcaine MPF w/EPI 0.25% (25 mg per 10 mL) (2.5 mg per mL) SDV (NDC 63323-468-17) Backordered. Next release May 2023. Check wholesalers for inventory. Demand increase for the drug
Sensorcaine MPF w/EPI .25% (75 mg per 30 mL) (2.5 mg per mL) SDV (NDC 63323-468-37) Backordered. Next release March 2023. Check wholesalers for inventory. Demand increase for the drug
Sensorcaine MPF w/EPI 0.5% (50 mg per 10 mL) (5 mg per mL) SDV (NDC 63323-462-17) Backordered. Next release April 2023. Check wholesalers for inventory. Demand increase for the drug
Sensorcaine MPF w/EPI 0.5% (150 mg per 30 mL) (5 mg per mL) SDV (NDC 63323-462-37) Backordered. Next release March 2023. Check wholesalers for inventory. Demand increase for the drug
Sensorcaine MPF w/EPI 0.5% (150 mg per 30 mL) (5 mg per mL) Sterile-Pak, SDV (NDC 63323-462-31) Backordered. Next release date not available at this time. Demand increase for the drug
Sensorcaine MPF w/EPI 0.75% (225 mg per 30 mL) (7.5 mg per mL) SDV (NDC 63323-460-37) Backordered. Next release not available at this time. Demand increase for the drug

Hospira, Inc., a Pfizer company (Revised 03/17/2023)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
25 mg/10 mL (2.5 mg/mL); Single Dose Glass Teartop Vial (NDC 00409-9042-01) Next Delivery: February 2024; Estimated Recovery: March 2024 Shortage per Manufacturer: Manufacturing Delay Other
75 mg/30 mL (2.5 mg/mL); Single Dose Glass Teartop Vial (NDC 00409-9042-17) Next Delivery: February 2024; Estimated Recovery: March 2024 Shortage per Manufacturer: Manufacturing Delay Other
125 mg/50 mL (2.5 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-9043-01) Next Delivery: February 2024; Estimated Recovery: March 2024 Shortage per Manufacturer: Manufacturing Delay Other
50 mg/10 mL (5 mg/mL); Single Dose Glass Teartop Vial (NDC 00409-9045-01) Next Delivery: February 2024; Estimated Recovery: March 2024 Shortage per Manufacturer: Manufacturing Delay Other
150 mg/30 mL (5 mg/mL); Single Dose Glass Teartop Vial (NDC 00409-9045-17) Next Delivery: February 2024; Estimated Recovery: March 2024 Shortage per Manufacturer: Manufacturing Delay Other
250 mg/50 mL (5 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-9046-01) Next Delivery: February 2024; Estimated Recovery: March 2024 Shortage per Manufacturer: Manufacturing Delay Other
Marcaine with Epinephrine 1:200,000 as the bitartrate 25 mg/10 mL (2.5 mg/mL 1:200,000); Single Dose Glass Fliptop Vial (NDC 00409-1746-10) Next Delivery: August 2023; Estimated Recovery: June 2024 Shortage per Manufacturer: Manufacturing Delay Other
Marcaine with Epinephrine 1:200,000 as the bitartrate 75 mg/30 mL (2.5 mg/mL 1:200,000); Single Dose Glass Fliptop Vial (NDC 00409-1746-30) Next Delivery: August 2023; Estimated Recovery: June 2024 Shortage per Manufacturer: Manufacturing Delay Other
Marcaine with Epinephrine 1:200,000 as the bitartrate 50 mg/10 mL (5 mg/mL 1:200,000); Single Dose Glass Fliptop Vial (NDC 00409-1749-10) Next Delivery: April 2023; Estimated Recovery: June 2024 Shortage per Manufacturer: Manufacturing Delay Other
Marcaine with Epinephrine 1:200,000 as the bitartrate 150 mg/30 mL (5 mg/mL 1:200,000); Single Dose Glass Fliptop Vial (NDC 00409-1749-29) Next Delivery: September 2023; Estimated Recovery: June 2024 Shortage per Manufacturer: Manufacturing Delay Other
Marcaine with Epinephrine 1:200,000 as the bitartrate 125 mg/50 mL (2.5 mg/mL 1:200,000); Multiple Dose Glass Fliptop Vial (NDC 00409-1752-50) Next Delivery and Estimated Recovery: March 2023 Shortage per Manufacturer: Manufacturing Delay Other
Marcaine with Epinephrine 1:200,000 as the bitartrate 250 mg/50 mL (5 mg/mL 1:200,000); Multiple Dose Glass Fliptop Vial (NDC 00409-1755-50) Next Delivery and Estimated Recovery: March 2023 Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay Other
Back to Top